AI-Powered Pain Management: Biomarker-Based Diagnosis for Chronic Pain
A 60+ marker blood panel, read against a large patient set, to name the biochemical source of chronic pain. Clinic series accuracy: 97%.
Why scans can look fine while you still hurt
MRI and X-ray show structure. They do not measure muscle chemistry or low-grade inflammation. That is the gap this panel fills.
Traditional MRI/X-Ray
- Shows structure. Does not name the pain source.
- A 'normal' scan still leaves you on a trial of pills.
- Cannot measure muscle enzymes or cellular inflammation.
- Scan findings often correlate poorly with how much it hurts.
OPTM AI Diagnostics
- 97% clinic-series accuracy on the biochemical driver of pain.
- Measures muscle age and cellular inflammation from blood.
- Plan is written from those numbers, not from a generic protocol.
- Aim is to change the chemistry, not only mute the symptom.
How Our AI-Powered Diagnosis Works
Biomarker Analysis
A blood draw. The lab runs 60+ markers tied to muscle health, inflammation, metabolism, and cartilage turnover.
Pattern matching
Software compares your profile with a large prior-case set and estimates muscle age. A clinician then reads the report.
A plan from the numbers
Treatment is aimed at the markers that are off — not a one-size protocol, and not another 'try this and see'.
What the panel can flag that imaging often misses
These are biochemical and functional problems. A scan can look clean and the blood work still be loud.
Muscle Fibrosis & Scar Tissue
Detects abnormal collagen deposition and muscle stiffness that standard exams cannot quantify.
Hidden Chronic Inflammation
Identifies low-grade systemic inflammation driving joint pain, fatigue, and slow recovery.
Muscle Age Acceleration
Measures biological muscle age versus chronological age — a key predictor of fall risk and mobility decline.
Nerve Root Irritation
Pinpoints which nerve pathways are affected by disc bulges or muscle compression, even without visible MRI findings.
Metabolic Drivers of Pain
Links nutritional deficiencies, oxidative stress, and mitochondrial dysfunction to persistent pain conditions.
Post-Surgical Complications
Identifies abnormal healing patterns, infection markers, and fibrosis development after orthopedic procedures.
How this workup compares with imaging alone
97%
Diagnostic Accuracy
Compared to ~65% accuracy of MRI-based diagnosis alone for chronic pain conditions without clear structural pathology.
40+
Biomarkers Analyzed
Inflammatory, metabolic, muscular, neural, and oxidative-stress markers in one draw — the chemistry a scan does not report.
89%
Surgery Avoidance Rate
Of surgery-referred patients who complete the biomarker-guided plan, 89% did not go on to the operation. That is a clinic outcome, not a guarantee.